Open AccessRituximab Induced Interstitial Lung Disease Diagnosis, Treatment Outcome, and Risk’s Factor, a Place for Transbronchial Pulmonary Cryobiopsy
Author(s) -
Douze Makenzi,
Vintila Sabina,
Jossart Adrien,
Praile Martin,
Klipper Dit Kurtz Noemie,
M. I. Padín Martín,
Mond Victoria,
Maeck Patricia
Publication year - 2021
Publication title -
case reports in clinical medicine
Language(s) - English
Resource type - Journals
eISSN - 2325-7075
pISSN - 2325-7083
DOI - 10.4236/crcm.2021.1010036
Subject(s) - medicine , rituximab , chills , interstitial lung disease , thrombocytopenic purpura , rheumatoid arthritis , immunology , cd20 , tocilizumab , autoimmune hemolytic anemia , pulmonary toxicity , gastroenterology , lung , lymphoma , antibody , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom